NAMILUMAB
UNII MED485W763

Substance Identification & Data

This profile provides standardized clinical and technical data for Namilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MED485W763.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1206681-39-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MED485W763

CAS Registry Number

1206681-39-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAMILUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97943

National Cancer Institute reference terminology for clinical and research data.

INN ID

9382

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Namilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NAMILUMAB

Common Names & Synonyms

ANTI-HGM-CSF IGG1

IMMUNOGLOBULIN G1, ANTI-(HUMAN COLONY-STIMULATING FACTOR 2) (HUMAN MONOCLONAL MT203 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MT203 .KAPPA.-CHAIN, DIMER

NAMILUMAB [INN]

NAMILUMAB [WHO-DD]